Arvinas has developed PROTAC® protein degraders, or PROteolysis -Targeting Chimeras which are novel molecules that direct the ubiquitin-proteasome system to specifically destroy disease-causing proteins, such as those causing cancer or neurodegenerative diseases.
Arvinas’ PROTAC® protein degrader technology is investigational. It’s safety and efficacy has not yet been established.
8 дек 2022